5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 15.28▲ | 15.28▲ | 15.28▲ | 14.95▲ | 15.27▲ |
MA10 | 15.79▼ | 15.78▼ | 15.78▼ | 14.65▲ | 15.38▲ |
MA20 | 16.36▼ | 16.39▼ | 16.46▼ | 15.25▲ | 17.25▼ |
MA50 | 16.18▼ | 16.20▼ | 16.19▼ | 15.68▼ | 16.23▼ |
MA100 | 17.64▼ | 18.23▼ | 18.31▼ | 17.38▼ | 16.54▼ |
MA200 | 19.43▼ | 18.70▼ | 18.68▼ | 16.63▼ | 25.04▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.139▼ | -0.127▼ | -0.124▼ | 0.071▲ | -0.321▼ |
RSI | 43.076▼ | 43.268▼ | 43.421▼ | 50.844▲ | 46.668▼ |
STOCH | 25.417 | 25.415 | 25.415 | 42.515 | 22.076 |
WILL %R | -62.397 | -62.397 | -62.397 | -28.358 | -82.878▼ |
CCI | -52.688 | -52.250 | -52.250 | 125.611▲ | -63.947 |
Tuesday, August 12, 2025 01:33 PM
Research & Development (R&D) Expenses: R&D expenses were $4.1 million and $3.4 million in each of the three months ended June 30, 2025, and 2024, respectively. The increase reflects higher indirect ...
|
Monday, August 11, 2025 05:55 AM
HIGH POINT, N.C., Aug. 11, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin, a potential first-in-class ...
|
Monday, August 11, 2025 05:10 AM
HIGH POINT, N.C., Aug. 11, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin, a potential first-in-class ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 15.44 | 15.44 | 15.44 | 15.44 | 900 |
14/08/25 | 15.84 | 16.01 | 14.80 | 15.30 | 5,700 |
13/08/25 | 14.00 | 14.03 | 14.00 | 14.03 | 1,600 |
12/08/25 | 14.49 | 14.49 | 14.49 | 14.49 | 800 |
11/08/25 | 14.75 | 15.678 | 14.75 | 15.473 | 2,100 |
08/08/25 | 14.00 | 14.00 | 14.00 | 14.00 | 891 |
07/08/25 | 14.48 | 14.48 | 14.099 | 14.099 | 600 |
06/08/25 | 14.618 | 14.618 | 14.618 | 14.618 | 0 |
05/08/25 | 14.6177 | 14.6177 | 14.6177 | 14.6177 | 279 |
04/08/25 | 14.75 | 14.75 | 14.4737 | 14.4737 | 652 |
|
|
||||
|
|
||||
|
|